modulating the therapeutic microenvironment using
play

Modulating the Therapeutic Microenvironment Using Nanostructured Materials Tej ejal A l A. Des esai, i, Ph PhD Ernest st L L Pr Prien Professo essor and C nd Chair Direc ector, UCSF E F Engineer eering and nd Appl pplied ed S

0 downloads 5 Views 3,19 MB Size Report
  1. Modulating the Therapeutic Microenvironment Using Nanostructured Materials Tej ejal A l A. Des esai, i, Ph PhD Ernest st L L Pr Prien Professo essor and C nd Chair Direc ector, UCSF E F Engineer eering and nd Appl pplied ed S Scien ences I es Initiative Dept. of Bioen engineer eering a and nd T Ther herape peutic S Scien ences es

  2. Advanced biomaterials for therapeutic delivery CANCER DIABETES HEART DISEASE PSORIASIS Size ARTHRITIS … Surface Material Shape  Direct biophysical stimulation  Biomolecule carrier/presenter Picture credit: Zhang, Drug Discovery Today

  3. How can material structure Micro and Cell –Material Nanostructures Interactions modulate biologic function for therapeutic purposes? Therapeutic Systems

  4. Desired Routes of Drug Delivery

  5. Challenges to epithelial drug delivery 5

  6. Revisiting the small intestine Length (m) 10 0 Small intestine 10 -2 Villi 10 -4 Enterocytes 10 -6 Microvilli 10 -8 Fox C et al., Journal of Controlled Release, 2015

  7. Drawbacks of paracellular permeation enhancers Membrane damage and Permeation enhancer cell toxicity (red) opens tight • Chemical permeation agents junctions for increased drug induce opening of tight permeation junctions • Examples: Surfactants, chelators, and toxins Non-reversible tight • Toxicity to cells junction damage • Non-reversible tight junction opening

  8. Opening Epithelial Barriers Sun et al. Physiological Reviews, 2017.

  9. Topographical cues can enhance permeation of drug between tight junctions Nanostructured Diameter: 200 nm Film Height: 300 nm High Drug Permeation Drug Molecule Cells Diameter: 800 nm Height: 16 µm Low Drug Permeation Kam et al., Nanoletters, 2014; Stewart et al., Exp. Cell Res, 2017

  10. Nanostructured microneedles enhance transdermal drug delivery Sun, et al. Physiological Reviews, 2017 Walsh, et al. Nano Lett, 2015

  11. Nanostructured planar particles for enhanced oral delivery 200 nm diameter Fox et al., JCR 2015 Fox et al. ACS Nano 2016

  12. Nanostructures can be tuned to facilitate permeation HD100 HD200 HD500 LD100 LD200 LD500

  13. The process is reversible and involves remodeling of tight junctions Remove c) b) a) d 10 µ m 10 µ m 10 µ m 20 µ m 20 µ m 20 µ m ZO-1 (tight junction protein), Caco-2 nuclei, F-Actin

  14. Paracellular or transcellular? Mechanism?

  15. FITC-IgG present at apical cell-cell borders

  16. TJ scaffolding protein ZO-1 shows altered morphologies upon NS film treatment Z-stack-1 Z-stack-2 Z-stack-3 Z-projection Total level keep the same  reversible

  17. CRISPR-based gene editing to visualize tight junctions Clone isolation Fluorescent protein fusion of TJP-ZO-1 Inserted allele ZO-1 Original allele mCherry Inserted allele Original allele After In Vitro barrier model screening ZO-1 proteins fused with mCherry-reporter at Endogenous ZO-1 ICC N-terminus through CRISPR mCherry-ZO1

  18. Dynamic changes in TJs with nanostructure contact NS NS Time-Lapse Video of ZO-1 during Nanostructure Treatment (MAX Z-projection, 2 locations 1s=5mins) TEER>>1800 10-40 mins 45-75 mins

  19. Large aggregates of ZO-1protein are formed on apical side when treated with NS film

  20. Active interaction between aggregates and border ZO-1

  21. NS-film treated cells have faster recovery from FRAP Photobleaching t = 300s t = 0s t = 100s t = 200s in frame NS-treated Non-treated

  22. Junctional protein Claudin-4 colocalizes with ZO-1 aggregates Video Non-treated NS Flat endogenous mCherry-ZO-1 + AAV exogenous YFP-Cldn3, Z projection of ~1um

  23. Using physical cues to alter tight junction permeability: implications for delivery

  24. Harnessing nanotopographical cues for therapy Epithelial Smooth Cells Endothelia Muscle l Cells Cells Fibroblasts

  25. Th The The Therapeutic M c Micr cro a and d Nanot otec echnol ology L Laboratory at UCSF  Dr. r. Xiao H Huang ng  Dr. r. Xiaoy oyu Sh Shi  Dr Dr. Anna C Celli elli  Dr. Camer eron N Nemeth • Mike ke Koval, l, E Emory • Thea ea Mauro, U , UCSF CSF • Bo Bo H Huang, U UCSF CSF • NIH H • NSF SF • Kimbe berl rly C Clark rke • Za Zamb mbone Ltd • SPA PARC • Eli L i Lill lly

Recommend Documents


the role of the lung microenvironment in
The Role of the Lung Microenvironment

4/20/2018 Cristina M. Alvira The Role of the Lung Microenvironment in Has

the tumor microenvironment and 3 d tumor models
The Tumor Microenvironment and 3-D

The Tumor Microenvironment and 3-D Tumor Models James Freyer Bioscience

an innovative multi dimensional ngs approach to
An innovative multi-dimensional NGS

An innovative multi-dimensional NGS approach to understanding the tumor

new anticancer agents targeting
New Anticancer Agents Targeting the

New Anticancer Agents Targeting the Tumor-Specific Microenvironment (OTT ID

assessing the tumor microenvironment
Assessing the Tumor Microenvironment

Assessing the Tumor Microenvironment by Recovery of Immune Receptor V(D)J

modulating therapies
modulating therapies: Prosensas DMD

The development of RNA- modulating therapies: Prosensas DMD programme Aktion

lipid modulating effects of evacetrapib a novel cetp
Lipid-Modulating Effects of

Lipid-Modulating Effects of Evacetrapib, a Novel CETP Inhibitor, Administered

gut microbial metabolism of food constituents modulating
Gut Microbial Metabolism of Food

Human Microbiome Science: Vision for the Future July 24-26, 2013, Bethesda,

the importance of seagrass in upper florida bay in
The Importance of Seagrass in Upper

The Importance of Seagrass in Upper Florida Bay in Modulating Flow, Waves, and

cholesterol transporters cholesterol transporters as new
Cholesterol transporters Cholesterol

Cholesterol transporters Cholesterol transporters as new therapeutic targets

the application of dna markers to monitoring adaptation
The application of DNA markers to

The application of DNA markers to monitoring adaptation and migration of

mentor christine e edwards
Mentor: Christine E. Edwards A

Rebekah A. Mohn Miami University, Oxford, Ohio mohnra@miamioh.edu Mentor:

building the best suite of content driven analytics
Building the best suite of

2019 Analyst & Investor Day Bioinformatics Building the best suite of

crosses incomplete dominance codominance
crosses incomplete dominance,

Use Punnett squares for unusual monohybrid crosses incomplete dominance,

presentation template
PRESENTATION TEMPLATE a Critical

SMA FOUNDATION Skeletal Muscle: PRESENTATION TEMPLATE a Critical Target in

pioneer a randomized double blind placebo controlled
PIONEER: A Randomized, Double-Blind,

PIONEER: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of

hope s for qantitative environm ental microbiological
HOPE( s) for Qantitative Environm

HOPE( s) for Qantitative Environm ental Microbiological Studies Wen-Tso Liu

mendelian
MENDELIAN RANDOMIZATION Maria

MENDELIAN RANDOMIZATION Maria Carolina Borges Research Fellow MRC

building the best uc tca submission with a community
Building the Best UC TCA Submission -

Building the Best UC TCA Submission - with a Community College Perspective

demystifying dna demystifying dna
Demystifying DNA Demystifying DNA

Demystifying DNA Demystifying DNA What is it? How do I get it? What is

two interesting cases of molecular diagnosis for hht
TWO INTERESTING CASES OF MOLECULAR

TWO INTERESTING CASES OF MOLECULAR DIAGNOSIS FOR HHT: LOW-LEVEL MOSAICISM

dna short tandem repeats
DNA Short Tandem Repeats Organism DNA

DNA Short Tandem Repeats Organism DNA Short Tandem Repeats Organ DNA Short